Clinical Trial Update: Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating venlafaxine (Effexor) for achieving response and maintaining remission in depression has completed. The sponsor is Wyeth, now a wholl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Effexor (venlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depression | Phase 4 | Status: COMPLETED